British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009

被引：982

作者：

Lim, W. S. ^{[1
]}

Baudouin, S. V. ^{[1
]}

George, R. C. ^{[1
]}

Hill, A. T. ^{[1
]}

Jamieson, C. ^{[1
]}

Le Jeune, I. ^{[1
]}

Macfarlane, J. T. ^{[1
]}

Read, R. C. ^{[1
]}

Roberts, H. J. ^{[1
]}

Levy, M. L. ^{[1
]}

Wani, M. ^{[1
]}

Woodhead, M. A. ^{[1
]}

机构：

[1] Univ Nottingham Hosp, Nottingham NG5 1PB, England

来源：

THORAX | 2009年 / 64卷

关键词：

RESISTANT-STAPHYLOCOCCUS-AUREUS; C-REACTIVE PROTEIN; MILD-TO-MODERATE; Q-FEVER PNEUMONIA; RESPIRATORY-TRACT INFECTION; PNEUMOCOCCAL MACROLIDE RESISTANCE; VENTILATOR-ASSOCIATED PNEUMONIA; OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; PROATRIAL NATRIURETIC PEPTIDE;

D O I：

10.1136/thx.2009.121434

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1 / 55

页数：55

共 502 条

[1] Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection
Aalto, Hannele
Takala, Annika
Kautiainen, Hannu
Siitonen, Sanna
Repo, Heikki
[J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (6-7) : 596 - 603
[2] Thoracic empyema in patients with community-acquired pneumonia
Ahmed, Rabia A.
Marrie, Thomas J.
Huang, Jane Q.
[J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (10) : 877 - 883
[3] Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia
Ailani, RK
Agastya, G
Ailani, RK
Mukunda, BN
Shekar, R
[J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) : 266 - 270
[4] THE OUTCOME OF COMMUNITY ACQUIRED PNEUMONIA TREATED ON THE INTENSIVE-CARE UNIT
ALKHAYER, M
JENKINS, PF
HARRISON, BDW
[J]. RESPIRATORY MEDICINE, 1990, 84 (01) : 13 - 16
[5] New evidence of risk factors for community-acquired pneumonia:: a population-based study
Almirall, J.
Bolibar, I.
Serra-Prat, M.
Roig, J.
Hospital, I.
Carandell, E.
Agusti, M.
Ayuso, P.
Estela, A.
Torres, A.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1274 - 1284
[6] Community-acquired pneumonia:: aetiologic changes in a limited geographic area.: An 11-year prospective study
Alvarez, R. Fernandez
Toste, I. Suarez
Cuadrado, G. Rubinos
Lana, A. Torres
Blanco, J. A. Gullon
Jimenez, A.
Martin, I. Gonzalez
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (07) : 495 - 499
[7] Pneumococcal macrolide resistance - myth or reality?
Amsden, GW
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) : 1 - 6
[8] Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia
Ananda-Rajah, Michelle R.
Charles, Patrick G. P.
Melvani, Sharmila
Burrell, Laurelle L.
Johnson, Paul D. R.
Grayson, M. Lindsay
[J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (04) : 293 - 300
[9] A COMPARATIVE SAFETY AND EFFICACY STUDY OF CLARITHROMYCIN AND ERYTHROMYCIN STEARATE IN COMMUNITY-ACQUIRED PNEUMONIA
ANDERSON, G
ESMONDE, TS
COLES, S
MACKLIN, J
CARNEGIE, C
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 : 117 - 124
[10] Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults
Andreo, F
Domínguez, J
Ruiz, J
Blanco, S
Arellano, E
Prat, C
Morera, J
Ausina, V
[J]. RESPIRATORY MEDICINE, 2006, 100 (05) : 884 - 891

← 1 2 3 4 5 6 7 8 9 10 →